Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Subscribe To Our Newsletter & Stay Updated
